{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:55:10Z","timestamp":1787028910306,"version":"build-2736575974"},"reference-count":42,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Metabolic dysfunction-associated fatty liver disease has become the most common chronic liver disease as well as the most common cause for liver transplantation. With its different methods types, elastography of the liver can be used for non-invasive evaluation of the liver fibrosis and steatosis degree. The article focuses on the description, use, advantages, and limitations of the currently known elastographic techniques. It proposes a simple risk assessment algorithm for the liver fibrosis progress evaluation. The following is an overview of the use of liver and spleen elastography in the detection of clinically relevant portal hypertension. It concludes with research and technological possibilities that could be important to the field in the upcoming years.<\/jats:p>","DOI":"10.3390\/medicina57060516","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:01:20Z","timestamp":1621814480000},"page":"516","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ultrasound Elastography\u2014Cornerstone of Non-Invasive Metabolic Dysfunction-Associated Fatty Liver Disease Assessment"],"prefix":"10.3390","volume":"57","author":[{"given":"Andrej","family":"Hari","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, General Hospital Celje, 3000 Celje, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/hep.31142","article-title":"Serial Transient Elastography Examinations to Monitor Patients With Type 2 Diabetes: A Prospective Cohort Study","volume":"72","author":"Lee","year":"2020","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"530","DOI":"10.4254\/wjh.v10.i8.530","article-title":"Current status of imaging in nonalcoholic fatty liver disease","volume":"10","author":"Li","year":"2018","journal-title":"World J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/postgradmedj-2018-136111","article-title":"Multiparametric ultrasound in liver diseases: An overview for the practising clinician","volume":"95","author":"Grgurevic","year":"2019","journal-title":"Postgrad. Med. J."},{"key":"ref_5","first-page":"101","article-title":"Imaging biomarkers of NAFLD, NASH, and fibrosis","volume":"15","author":"Ajmera","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"100067","DOI":"10.1016\/j.jhepr.2020.100067","article-title":"Limitations of non-invasive tests for assessment of liver fibrosis","volume":"20","author":"Patel","year":"2020","journal-title":"JHEP Rep."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Oeda, S., Tanaka, K., Oshima, A., Matsumoto, Y., Sueoka, E., and Takahashi, H. (2020). Diagnostic Accuracy of FibroScan and Factors Affecting Measurements. Diagnostics, 10.","DOI":"10.3390\/diagnostics10110940"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Cassinotto, C., Boursier, J., Paisant, A., Guiu, B., Irles-Depe, M., Canivet, C., Aube, C., and de Ledinghen, V. (2020). Transient Versus 2-Dimensional Shear-Wave Elastography in a Multistep Strategy to Detect Advanced Fibrosis in NAFLD. Hepatology, Online ahead of print.","DOI":"10.1002\/hep.31655"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/gutjnl-2018-317593","article-title":"Advances in non-invasive assessment of hepatic fibrosis","volume":"69","author":"Loomba","year":"2020","journal-title":"Gut"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0035-1567037","article-title":"Ultrasound Shear Wave Elastography for Liver Disease. A Critical Appraisal of the Many Actors on the Stage","volume":"37","author":"Piscaglia","year":"2016","journal-title":"Ultraschall Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Chimoriya, R., Piya, M.K., Simmons, D., Ahlenstiel, G., and Ho, V. (2020). The Use of Two-Dimensional Shear Wave Elastography in People with Obesity for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease. J. Clin. Med., 29.","DOI":"10.3390\/jcm10010095"},{"key":"ref_12","first-page":"8859338","article-title":"Transient Elastography in Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis","volume":"20","author":"Cai","year":"2021","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_14","first-page":"338","article-title":"Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease","volume":"8","author":"Papatheodoridi","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1111\/jgh.14978","article-title":"Liver stiffness measurement in non-alcoholic fatty liver disease: Two is better than one","volume":"35","author":"Chuah","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.ultrasmedbio.2018.07.008","article-title":"Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations","volume":"44","author":"Ferraioli","year":"2018","journal-title":"Ultrasound. Med. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1007\/s10620-019-05883-1","article-title":"Usefulness of Controlled Attenuation Parameter in Detecting and Monitoring Hepatic Steatosis with MRI-PDFF as Reference","volume":"65","author":"Wang","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3748\/wjg.v25.i11.1307","article-title":"Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice","volume":"25","author":"Zhou","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/17474124.2019.1608820","article-title":"Noninvasive monitoring of hepatic steatosis: Controlled attenuation parameter and magnetic resonance imaging-proton density fat fraction in patients with nonalcoholic fatty liver disease","volume":"13","author":"Sol","year":"2019","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.29639","article-title":"Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis","volume":"67","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/2050640619900820","article-title":"Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis","volume":"8","author":"Semmler","year":"2020","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S2468-1253(20)30357-5","article-title":"Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: An individual patient data meta-analysis","volume":"6","author":"Petroff","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10396-020-01058-y","article-title":"T.; Yoshida, M.; Iijima, H. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: New trends and role of ultrasonography","volume":"47","author":"Tada","year":"2020","journal-title":"J. Med. Ultrason."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3748\/wjg.v25.i3.308","article-title":"Elastography-based screening for esophageal varices in patients with advanced chronic liver disease","volume":"25","author":"Paternostro","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1007\/s12072-020-10062-w","article-title":"Spleen stiffness measurement for assessing the response to \u03b2-blockers therapy for high-risk esophageal varices patients","volume":"14","author":"Marasco","year":"2020","journal-title":"Hepatol. Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jhep.2018.04.023","article-title":"A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease","volume":"69","author":"Colecchia","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jhep.2018.05.019","article-title":"Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis","volume":"69","author":"Petta","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_29","first-page":"S1542","article-title":"Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require Treatment","volume":"17","author":"Berger","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/liv.13560","article-title":"A new screening strategy for varices by liver and spleen stiffness measurement (LSSM) in cirrhotic patients: A randomized trial","volume":"38","author":"Wong","year":"2018","journal-title":"Liver Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/hep.30522","article-title":"Low Risk of Variceal Bleeding in Patients With Cirrhosis After Variceal Screening Stratified by Liver\/Spleen Stiffness","volume":"70","author":"Wong","year":"2019","journal-title":"Hepatology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.cgh.2020.06.045","article-title":"Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease","volume":"19","author":"Petta","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive Assessment of Liver Disease in Patients with Nonalcoholic Fatty Liver Disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/liv.14325","article-title":"Controlled attenuation parameter reflects steatosis in compensated advanced chronic liver disease","volume":"40","author":"Piccinni","year":"2020","journal-title":"Liver Int."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1111\/liv.14426","article-title":"Steatosis assessment by controlled attenuation parameter in patients with compensated advanced chronic liver disease","volume":"40","author":"Grgurevic","year":"2020","journal-title":"Liver Int."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/hep4.1201","article-title":"Prognostic Significance of Controlled Attenuation Parameter in Patients With Compensated Advanced Chronic Liver Disease","volume":"2","author":"Margini","year":"2018","journal-title":"Hepatol. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Vuppalanchi, R., and Loomba, R. (2021). Non-invasive Tests to Phenotype Nonalcoholic Fatty Liver Disease\u2014Sequence and Consequences of Arranging the Tools in the Tool Box. Hepatology.","DOI":"10.1002\/hep.31734"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.31661\/jbpe.v0i0.2009-1180","article-title":"Implementation of Combinational Deep Learning Algorithm for Non-alcoholic Fatty Liver Classification in Ultrasound Images","volume":"11","author":"Zamanian","year":"2021","journal-title":"J. Biomed. Phys. Eng."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Noureddin, M. (2021). Artificial Intelligence in NASH Histology: Human Teaches a Machine for the Machine to help Humans. Hepatology, Online ahead of print.","DOI":"10.1002\/hep.31777"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1148\/radiol.2020192665","article-title":"The Role of Multiparametric US of the Liver for the Evaluation of Nonalcoholic Steatohepatitis","volume":"296","author":"Sugimoto","year":"2020","journal-title":"Radiology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.dld.2017.11.019","article-title":"Novel ultrasound-based methods to assess liver disease: The game has just begun","volume":"50","author":"Berzigotti","year":"2018","journal-title":"Dig. Liver Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.14366\/usg.20042","article-title":"Quantitative ultrasound radiofrequency data analysis for the assessment of hepatic steatosis using the controlled attenuation parameter as a reference standard","volume":"40","author":"Jeon","year":"2021","journal-title":"Ultrasonography"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/6\/516\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:05:36Z","timestamp":1760162736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/6\/516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,21]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["medicina57060516"],"URL":"https:\/\/doi.org\/10.3390\/medicina57060516","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,21]]}}}